TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs11150038
log Bayes Factor = <0.0001
Chromosome 16   position 78,076,559  (GRCh37) Explore rs11150038 on Ensembl!
Variant rs11150038 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.970 0.030
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.970 0.030
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.972 0.028
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.973 0.027
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.975 0.025
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.976 0.024
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.976 0.023
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.977 0.023
T43.9 Psychotropic drug, unspecified
0.000 0.977 0.023
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.978 0.022
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.978 0.022
T36 Poisoning by systemic antibiotics
0.000 0.978 0.021
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.979 0.021
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.979 0.021
T39.0 Salicylates
0.000 0.979 0.021
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.979 0.021
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.979 0.021
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.980 0.020
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.980 0.020
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.980 0.020
T43.2 Other and unspecified antidepressants
0.000 0.980 0.020
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.980 0.020
T43.6 Psychostimulants with abuse potential
0.000 0.981 0.019
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.981 0.019
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.981 0.019
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.981 0.019
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.981 0.019
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.982 0.018
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.982 0.018
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.982 0.018
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.982 0.018
T45.0 Antiallergic and antiemetic drugs
0.000 0.982 0.018
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.982 0.017
T45.4 Iron and its compounds
0.000 0.982 0.017
T36.0 Penicillins
0.000 0.983 0.017
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.983 0.017
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.983 0.017
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.983 0.017
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.983 0.017
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.983 0.017
T44.0 Anticholinesterase agents
0.000 0.983 0.017
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.983 0.017
T42.1 Iminostilbenes
0.000 0.983 0.017
T45.5 Anticoagulants
0.000 0.983 0.017
T36.3 Macrolides
0.000 0.983 0.017
T39.4 Antirheumatics, not elsewhere classified
0.000 0.983 0.017
T39.2 Pyrazolone derivatives
0.000 0.983 0.017
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.983 0.017
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.983 0.016
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.984 0.016
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.984 0.016
T50.8 Diagnostic agents
0.000 0.984 0.016
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.984 0.016
T45.8 Other primarily systemic and haematological agents
0.000 0.984 0.016
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.984 0.016
T45.6 Fibrinolysis-affecting drugs
0.000 0.984 0.016
T45.3 Enzymes, not elsewhere classified
0.000 0.984 0.016
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.984 0.016
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.984 0.016
T36.9 Systemic antibiotic, unspecified
0.000 0.984 0.016
T36.7 Antifungal antibiotics, systemically used
0.000 0.984 0.016
T36.6 Rifamycins
0.000 0.984 0.016
T36.5 Aminoglycosides
0.000 0.984 0.016
T36.2 Chloramphenicol group
0.000 0.984 0.016
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.984 0.016
T36.4 Tetracyclines
0.000 0.984 0.015
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.984 0.016
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.984 0.015
T46.7 Peripheral vasodilators
0.000 0.984 0.015
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.984 0.015
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.984 0.015
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.984 0.015
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.984 0.015
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.985 0.015
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.985 0.015
T36.8 Other systemic antibiotics
0.000 0.985 0.015
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.985 0.015
T42.2 Succinimides and oxazolidinediones
0.000 0.985 0.015
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.985 0.015
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.985 0.015
T50.7 Analeptics and opioid receptor antagonists
0.000 0.985 0.015
T50.5 Appetite depressants
0.000 0.985 0.015
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.985 0.015
T50.0 Mineralocorticoids and their antagonists
0.000 0.985 0.015
T50.4 Drugs affecting uric acid metabolism
0.000 0.985 0.015
T47.0 Histamine H(2)-receptor antagonists
0.000 0.985 0.015
T42.3 Barbiturates
0.000 0.985 0.015
T45.2 Vitamins, not elsewhere classified
0.000 0.985 0.015
D70 Agranulocytosis
0.015 0.985 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.985 0.015
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.985 0.014
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.985 0.014
T47.7 Emetics
0.000 0.985 0.014
T47.5 Digestants
0.000 0.985 0.014
T47.3 Saline and osmotic laxatives
0.000 0.985 0.014
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.985 0.014
T37.5 Antiviral drugs
0.000 0.985 0.014
T37.4 Anthelminthics
0.000 0.985 0.014
T37.3 Other antiprotozoal drugs
0.000 0.985 0.014
T37.1 Antimycobacterial drugs
0.000 0.985 0.014
T37.0 Sulphonamides
0.000 0.985 0.014
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.985 0.014
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.985 0.014
T47.4 Other laxatives
0.000 0.985 0.014
T50.1 Loop [high-ceiling] diuretics
0.000 0.985 0.014
T47.2 Stimulant laxatives
0.000 0.985 0.014
D70-D77 Other diseases of blood and blood-forming organs
0.014 0.986 0.000
H83.0 Labyrinthitis
0.014 0.986 0.000
D73 Diseases of spleen
0.014 0.986 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.986 0.014
T48.4 Expectorants
0.000 0.986 0.014
T48.3 Antitussives
0.000 0.986 0.014
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.986 0.014
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.986 0.014
T48.0 Oxytocic drugs
0.000 0.986 0.014
T48.5 Anti-common-cold drugs
0.000 0.986 0.014
D73.0 Hyposplenism
0.014 0.986 0.000
T47.6 Antidiarrhoeal drugs
0.000 0.986 0.014
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.986 0.014
T41.5 Therapeutic gases
0.000 0.986 0.014
T41.4 Anaesthetic, unspecified
0.000 0.986 0.014
T41.3 Local anaesthetics
0.000 0.986 0.014
T41.1 Intravenous anaesthetics
0.000 0.986 0.014
T41.0 Inhaled anaesthetics
0.000 0.986 0.014
T46.1 Calcium-channel blockers
0.000 0.986 0.014
T38.9 Other and unspecified hormone antagonists
0.000 0.986 0.014
T38.7 Androgens and anabolic congeners
0.000 0.986 0.014
T38.4 Oral contraceptives
0.000 0.986 0.014
T38.2 Antithyroid drugs
0.000 0.986 0.014
T40.2 Other opioids
0.000 0.986 0.014
T49.9 Topical agent, unspecified
0.000 0.986 0.014
T49.8 Other topical agents
0.000 0.986 0.014
T49.7 Dental drugs, topically applied
0.000 0.986 0.014
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.986 0.014
T49.5 Ophthalmological drugs and preparations
0.000 0.986 0.014
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.986 0.014
T49.3 Emollients, demulcents and protectants
0.000 0.986 0.014
T49.2 Local astringents and local detergents
0.000 0.986 0.014
T49.1 Antipruritics
0.000 0.986 0.014
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.986 0.014
T40.3 Methadone
0.000 0.986 0.014
T42.0 Hydantoin derivatives
0.000 0.986 0.013
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.986 0.013
T41.2 Other and unspecified general anaesthetics
0.000 0.986 0.013
T38.5 Other oestrogens and progestogens
0.000 0.987 0.013
T38.0 Glucocorticoids and synthetic analogues
0.000 0.987 0.013
D75 Other diseases of blood and blood-forming organs
0.013 0.987 0.000
T40.6 Other and unspecified narcotics
0.000 0.987 0.013
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.987 0.013
T40.8 Lysergide [LSD]
0.000 0.987 0.013
T40.7 Cannabis (derivatives)
0.000 0.987 0.013
T40.0 Opium
0.000 0.987 0.013
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.987 0.013
T40.1 Heroin
0.000 0.987 0.013
T38.1 Thyroid hormones and substitutes
0.000 0.987 0.013
T40.5 Cocaine
0.000 0.988 0.012
T42.4 Benzodiazepines
0.000 0.988 0.012
T39.1 4-Aminophenol derivatives
0.000 0.988 0.012
H83 Other diseases of inner ear
0.012 0.988 0.000
D73.4 Cyst of spleen
0.011 0.989 0.000
D75.8 Other specified diseases of blood and blood-forming organs
0.011 0.989 0.000
D73.8 Other diseases of spleen
0.011 0.989 0.000
D73.5 Infarction of spleen
0.011 0.989 0.000
H81.0 Meniere's disease
0.011 0.989 0.000
Z98.8 Other specified postsurgical states
0.011 0.989 0.000
Z98.0 Intestinal bypass and anastomosis status
0.011 0.989 0.000
D75.9 Disease of blood and blood-forming organs, unspecified
0.011 0.989 0.000
D74 Methaemoglobinaemia
0.011 0.989 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.011 0.989 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.011 0.989 0.000
D73.2 Chronic congestive splenomegaly
0.010 0.989 0.000
D75.1 Secondary polycythaemia
0.011 0.989 0.000
T40.4 Other synthetic narcotics
0.000 0.989 0.010
D73.1 Hypersplenism
0.010 0.989 0.000
D75.0 Familial erythrocytosis
0.010 0.989 0.000
D72 Other disorders of white blood cells
0.010 0.989 0.000
D73.3 Abscess of spleen
0.010 0.990 0.000
D73.9 Disease of spleen, unspecified
0.010 0.990 0.000
D75.2 Essential thrombocytosis
0.010 0.990 0.000
Z98 Other postsurgical states
0.010 0.990 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.010 0.990 0.000
H81 Disorders of vestibular function
0.009 0.991 0.000
H80-H83 Diseases of inner ear
0.009 0.991 0.000
H83.8 Other specified diseases of inner ear
0.009 0.991 0.000
H83.3 Noise effects on inner ear
0.009 0.991 0.000
H83.1 Labyrinthine fistula
0.008 0.991 0.000
H83.2 Labyrinthine dysfunction
0.008 0.991 0.000
Z98.2 Presence of cerebrospinal fluid drainage device
0.008 0.992 0.000
D72.8 Other specified disorders of white blood cells
0.008 0.992 0.000
H83.9 Disease of inner ear, unspecified
0.008 0.992 0.000
D74.9 Methaemoglobinaemia, unspecified
0.008 0.992 0.000
D74.8 Other methaemoglobinaemias
0.008 0.992 0.000
D74.0 Congenital methaemoglobinaemia
0.008 0.992 0.000
D72.9 Disorder of white blood cells, unspecified
0.008 0.992 0.000
D72.0 Genetic anomalies of leukocytes
0.008 0.992 0.000
H80 Otosclerosis
0.007 0.993 0.000
D76.2 Haemophagocytic syndrome, infection-associated
0.007 0.993 0.000
D76.1 Haemophagocytic lymphohistiocytosis
0.007 0.993 0.000
D76.0 Langerhans' cell histiocytosis, not elsewhere classified
0.007 0.993 0.000
H81.1 Benign paroxysmal vertigo
0.007 0.993 0.000
Z98.1 Arthrodesis status
0.007 0.993 0.000
H81.4 Vertigo of central origin
0.007 0.993 0.000
H81.2 Vestibular neuronitis
0.007 0.993 0.000
H82 Vertiginous syndromes in diseases classified elsewhere
0.007 0.993 0.000
D72.1 Eosinophilia
0.007 0.993 0.000
H81.8 Other disorders of vestibular function
0.007 0.993 0.000
H81.3 Other peripheral vertigo
0.006 0.993 0.000
D76.3 Other histiocytosis syndromes
0.006 0.993 0.000
H80.9 Otosclerosis, unspecified
0.006 0.994 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.006 0.994 0.000
H80.0 Otosclerosis involving oval window, nonobliterative
0.006 0.994 0.000
H80.2 Cochlear otosclerosis
0.005 0.994 0.000
H80.1 Otosclerosis involving oval window, obliterative
0.005 0.994 0.000
H81.9 Disorder of vestibular function, unspecified
0.005 0.994 0.000
H80.8 Other otosclerosis
0.005 0.995 0.000
D55-D59 Haemolytic anaemias
0.005 0.995 0.000
D61.9 Aplastic anaemia, unspecified
0.005 0.995 0.000
D61 Other aplastic anaemias
0.005 0.995 0.000
D60-D64 Aplastic and other anaemias
0.005 0.995 0.000
C90.0 Multiple myeloma
0.005 0.995 0.000
Q21.1 Atrial septal defect
0.005 0.995 0.000
S72.00 Fracture of neck of femur (closed)
0.000 0.995 0.005
E04.1 Non-toxic single thyroid nodule
0.000 0.995 0.005
Z92.4 Personal history of major surgery, not elsewhere classified
0.004 0.996 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.004 0.996 0.000
D56 Thalassaemia
0.004 0.996 0.000
D58 Other hereditary haemolytic anaemias
0.004 0.996 0.000
X62.9 Unspecified place
0.000 0.996 0.004
D59 Acquired haemolytic anaemia
0.004 0.996 0.000
Q21 Congenital malformations of cardiac septa
0.004 0.996 0.000
D50-D53 Nutritional anaemias
0.004 0.996 0.000
D61.1 Drug-induced aplastic anaemia
0.004 0.996 0.000
D66 Hereditary factor VIII deficiency
0.004 0.996 0.000
D55 Anaemia due to enzyme disorders
0.004 0.996 0.000
S72.10 Pertrochanteric fracture (closed)
0.000 0.996 0.004
D63 Anaemia in chronic diseases classified elsewhere
0.004 0.996 0.000
D57 Sickle-cell disorders
0.004 0.996 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.004 0.996 0.000
D61.8 Other specified aplastic anaemias
0.004 0.996 0.000
D61.3 Idiopathic aplastic anaemia
0.004 0.996 0.000
D61.2 Aplastic anaemia due to other external agents
0.004 0.996 0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.004 0.996 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.000 0.996 0.004
D58.0 Hereditary spherocytosis
0.004 0.996 0.000
D62 Acute posthaemorrhagic anaemia
0.004 0.996 0.000
D61.0 Constitutional aplastic anaemia
0.003 0.996 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.004 0.996 0.000
D56.1 Beta thalassaemia
0.003 0.996 0.000
S72.0 Fracture of neck of femur
0.000 0.996 0.004
Q20-Q28 Congenital malformations of the circulatory system
0.004 0.996 0.000
D63.0 Anaemia in neoplastic disease
0.003 0.996 0.000
D58.9 Hereditary haemolytic anaemia, unspecified
0.003 0.996 0.000
D51 Vitamin B12 deficiency anaemia
0.003 0.997 0.000
D56.9 Thalassaemia, unspecified
0.003 0.997 0.000
D53 Other nutritional anaemias
0.003 0.997 0.000
D56.3 Thalassaemia trait
0.003 0.997 0.000
D59.1 Other autoimmune haemolytic anaemias
0.003 0.997 0.000
D59.4 Other nonautoimmune haemolytic anaemias
0.003 0.997 0.000
D56.8 Other thalassaemias
0.003 0.997 0.000
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]
0.003 0.997 0.000
D56.2 Delta-beta thalassaemia
0.003 0.997 0.000
D56.0 Alpha thalassaemia
0.003 0.997 0.000
Q21.9 Congenital malformation of cardiac septum, unspecified
0.003 0.997 0.000
D68 Other coagulation defects
0.003 0.997 0.000
X60-X84 Intentional self-harm
0.000 0.997 0.003
D58.8 Other specified hereditary haemolytic anaemias
0.003 0.997 0.000
D58.1 Hereditary elliptocytosis
0.003 0.997 0.000
D59.9 Acquired haemolytic anaemia, unspecified
0.003 0.997 0.000
Q21.3 Tetralogy of Fallot
0.003 0.997 0.000
D67 Hereditary factor IX deficiency
0.003 0.997 0.000
S72.1 Pertrochanteric fracture
0.000 0.997 0.003
D59.8 Other acquired haemolytic anaemias
0.003 0.997 0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes
0.003 0.997 0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
0.003 0.997 0.000
D59.3 Haemolytic-uraemic syndrome
0.003 0.997 0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia
0.003 0.997 0.000
D59.0 Drug-induced autoimmune haemolytic anaemia
0.003 0.997 0.000
Q21.0 Ventricular septal defect
0.003 0.997 0.000
Q21.4 Aortopulmonary septal defect
0.003 0.997 0.000
Q21.2 Atrioventricular septal defect
0.003 0.997 0.000
Q23 Congenital malformations of aortic and mitral valves
0.003 0.997 0.000
Q21.8 Other congenital malformations of cardiac septa
0.003 0.997 0.000
Q24 Other congenital malformations of heart
0.003 0.997 0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.003 0.997 0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.000 0.997 0.003
D80-D89 Certain disorders involving the immune mechanism
0.003 0.997 0.000
D55.9 Anaemia due to enzyme disorder, unspecified
0.003 0.997 0.000
D55.8 Other anaemias due to enzyme disorders
0.003 0.997 0.000
D55.3 Anaemia due to disorders of nucleotide metabolism
0.003 0.997 0.000
D55.2 Anaemia due to disorders of glycolytic enzymes
0.003 0.997 0.000
D55.1 Anaemia due to other disorders of glutathione metabolism
0.003 0.997 0.000
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
0.003 0.997 0.000
D63.1 Anaemia in other chronic diseases classified elsewhere
0.003 0.997 0.000
Z36.8 Other antenatal screening
0.003 0.997 0.000
C90.2 Plasmacytoma, extramedullary
0.003 0.997 0.000
X62.8 Other specified place
0.000 0.997 0.003
C90.1 Plasma cell leukaemia
0.003 0.997 0.000
D57.8 Other sickle-cell disorders
0.003 0.997 0.000
D57.2 Double heterozygous sickling disorders
0.003 0.997 0.000
D57.0 Sickle-cell anaemia with crisis
0.003 0.997 0.000
D58.2 Other haemoglobinopathies
0.003 0.997 0.000
Q28 Other congenital malformations of circulatory system
0.003 0.997 0.000
Q27 Other congenital malformations of peripheral vascular system
0.003 0.997 0.000
D57.3 Sickle-cell trait
0.003 0.997 0.000
D60.9 Acquired pure red cell aplasia, unspecified
0.003 0.997 0.000
D60.8 Other acquired pure red cell aplasias
0.003 0.997 0.000
D60.1 Transient acquired pure red cell aplasia
0.003 0.997 0.000
D60.0 Chronic acquired pure red cell aplasia
0.003 0.997 0.000
Q22 Congenital malformations of pulmonary and tricuspid valves
0.003 0.997 0.000
X60.8 Other specified place
0.000 0.997 0.003
D53.9 Nutritional anaemia, unspecified
0.003 0.997 0.000
X62.0 Home
0.000 0.997 0.003
X62.7 Farm
0.000 0.997 0.003
X62.6 Industrial and construction area
0.000 0.997 0.003
X62.5 Trade and service area
0.000 0.997 0.003
X62.4 Street and highway
0.000 0.997 0.003
X62.3 Sports and athletics area
0.000 0.997 0.003
X62.2 School, other institution and public administrative area
0.000 0.997 0.003
X62.1 Residential institution
0.000 0.997 0.003
X68 Intentional self-poisoning by and exposure to pesticides
0.000 0.997 0.003
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system
0.000 0.997 0.003
D57.1 Sickle-cell anaemia without crisis
0.003 0.997 0.000
D68.8 Other specified coagulation defects
0.003 0.997 0.000
X78 Intentional self-harm by sharp object
0.000 0.997 0.003
X65 Intentional self-poisoning by and exposure to alcohol
0.000 0.997 0.003
D68.9 Coagulation defect, unspecified
0.003 0.997 0.000
Q23.1 Congenital insufficiency of aortic valve
0.003 0.997 0.000
S72.01 Fracture of neck of femur (open)
0.000 0.997 0.003
C90.3 Solitary plasmacytoma
0.003 0.997 0.000
D68.5 Primary Thrombophilia
0.003 0.997 0.000
Q24.8 Other specified congenital malformations of heart
0.003 0.997 0.000
D52 Folate deficiency anaemia
0.003 0.997 0.000
Q24.9 Congenital malformation of the heart, unspecified
0.003 0.997 0.000
Q20 Congenital malformations of cardiac chambers and connexions
0.003 0.997 0.000
S72 Fracture of femur
0.000 0.997 0.003
X84 Intentional self-harm by unspecified means
0.000 0.997 0.003
D68.1 Hereditary factor XI deficiency
0.003 0.997 0.000
Q26 Congenital malformations of great veins
0.003 0.997 0.000
D51.3 Other dietary vitamin B12 deficiency anaemia
0.003 0.997 0.000
D51.2 Transcobalamin II deficiency
0.003 0.997 0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.003 0.997 0.000
Q28.2 Arteriovenous malformation of cerebral vessels
0.003 0.997 0.000
Q25 Congenital malformations of great arteries
0.003 0.997 0.000
J33.0 Polyp of nasal cavity
0.000 0.997 0.003
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.000 0.997 0.003
D53.8 Other specified nutritional anaemias
0.003 0.997 0.000
D53.2 Scorbutic anaemia
0.003 0.997 0.000
D53.0 Protein deficiency anaemia
0.003 0.997 0.000
Q23.0 Congenital stenosis of aortic valve
0.003 0.997 0.000
X83 Intentional self-harm by other specified means
0.000 0.997 0.003
D53.1 Other megaloblastic anaemias, not elsewhere classified
0.003 0.997 0.000
D68.4 Acquired coagulation factor deficiency
0.003 0.997 0.000
X63.0 Home
0.000 0.997 0.003
M19.07 Primary arthrosis of other joints (Ankle and foot)
0.000 0.997 0.003
X68.9 Unspecified place
0.000 0.997 0.003
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.000 0.997 0.003
Q23.3 Congenital mitral insufficiency
0.003 0.997 0.000
X60.5 Trade and service area
0.000 0.997 0.003
X80 Intentional self-harm by jumping from a high place
0.000 0.997 0.003
Q24.6 Congenital heart block
0.003 0.997 0.000
X82 Intentional self-harm by crashing of motor vehicle
0.000 0.997 0.003
X81 Intentional self-harm by jumping or lying before moving object
0.000 0.997 0.003
X79 Intentional self-harm by blunt object
0.000 0.997 0.003
X77 Intentional self-harm by steam, hot vapours and hot objects
0.000 0.997 0.003
X76 Intentional self-harm by smoke, fire and flames
0.000 0.997 0.003
X75 Intentional self-harm by explosive material
0.000 0.997 0.003
X74 Intentional self-harm by other and unspecified firearm discharge
0.000 0.997 0.003
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge
0.000 0.997 0.003
X72 Intentional self-harm by handgun discharge
0.000 0.997 0.003
X71 Intentional self-harm by drowning and submersion
0.000 0.997 0.003
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
0.000 0.997 0.003
S72.11 Pertrochanteric fracture (open)
0.000 0.997 0.002
D51.8 Other vitamin B12 deficiency anaemias
0.002 0.997 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.003 0.997 0.000
Q24.4 Congenital subaortic stenosis
0.002 0.997 0.000
D63.8 Anaemia in other chronic diseases classified elsewhere
0.002 0.997 0.000
X78.0 Home
0.000 0.997 0.003
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.002 0.997 0.000
X70 Intentional self-harm by hanging, strangulation and suffocation
0.000 0.997 0.002
Q23.9 Congenital malformation of aortic and mitral valves, unspecified
0.002 0.997 0.000
Q23.8 Other congenital malformations of aortic and mitral valves
0.002 0.997 0.000
Q23.4 Hypoplastic left heart syndrome
0.002 0.997 0.000
Q23.2 Congenital mitral stenosis
0.002 0.997 0.000
X65.8 Other specified place
0.000 0.997 0.002
Q24.3 Pulmonary infundibular stenosis
0.002 0.997 0.000
Q24.2 Cor triatriatum
0.002 0.997 0.000
Q24.1 Levocardia
0.002 0.997 0.000
Q27.8 Other specified congenital malformations of peripheral vascular system
0.002 0.997 0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours
0.000 0.997 0.002
D68.0 Von Willebrand's disease
0.002 0.997 0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.000 0.997 0.002
Q24.0 Dextrocardia
0.002 0.997 0.000
X60.9 Unspecified place
0.000 0.997 0.002
X60.0 Home
0.000 0.997 0.002
X60.7 Farm
0.000 0.997 0.002
X60.6 Industrial and construction area
0.000 0.997 0.002
X60.4 Street and highway
0.000 0.997 0.002
X60.3 Sports and athletics area
0.000 0.997 0.002
X60.1 Residential institution
0.000 0.997 0.002
D83 Common variable immunodeficiency
0.002 0.997 0.000
Q22.5 Ebstein's anomaly
0.002 0.997 0.000
Q22.1 Congenital pulmonary valve stenosis
0.002 0.997 0.000
D82 Immunodeficiency associated with other major defects
0.002 0.997 0.000
D81 Combined immunodeficiencies
0.002 0.997 0.000
Q27.1 Congenital renal artery stenosis
0.002 0.997 0.000
D80 Immunodeficiency with predominantly antibody defects
0.002 0.997 0.000
D68.6 Other Thrombophilia
0.002 0.998 0.000
Q27.3 Peripheral arteriovenous malformation
0.002 0.998 0.000
Q28.3 Other malformations of cerebral vessels
0.002 0.998 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.002 0.998 0.000
Q28.9 Congenital malformation of circulatory system, unspecified
0.002 0.998 0.000
Q28.8 Other specified congenital malformations of circulatory system
0.002 0.998 0.000
Q28.1 Other malformations of precerebral vessels
0.002 0.998 0.000
Z92.3 Personal history of irradiation
0.002 0.998 0.000
Q24.5 Malformation of coronary vessels
0.002 0.998 0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified
0.002 0.998 0.000
Q27.4 Congenital phlebectasia
0.002 0.998 0.000
Q27.2 Other congenital malformations of renal artery
0.002 0.998 0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery
0.002 0.998 0.000
X60.2 School, other institution and public administrative area
0.000 0.998 0.002
Q22.9 Congenital malformation of tricuspid valve, unspecified
0.002 0.998 0.000
Q22.8 Other congenital malformations of tricuspid valve
0.002 0.998 0.000
Q22.6 Hypoplastic right heart syndrome
0.002 0.998 0.000
Q22.4 Congenital tricuspid stenosis
0.002 0.998 0.000
Q22.3 Other congenital malformations of pulmonary valve
0.002 0.998 0.000
Q22.2 Congenital pulmonary valve insufficiency
0.002 0.998 0.000
Q22.0 Pulmonary valve atresia
0.002 0.998 0.000
X84.9 Unspecified place
0.000 0.998 0.002
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity
0.000 0.998 0.002
Q25.1 Coarctation of aorta
0.002 0.998 0.000
X63.9 Unspecified place
0.000 0.998 0.002
X63.8 Other specified place
0.000 0.998 0.002
X63.7 Farm
0.000 0.998 0.002
X63.6 Industrial and construction area
0.000 0.998 0.002
X63.5 Trade and service area
0.000 0.998 0.002
X63.4 Street and highway
0.000 0.998 0.002
X63.3 Sports and athletics area
0.000 0.998 0.002
X63.2 School, other institution and public administrative area
0.000 0.998 0.002
X63.1 Residential institution
0.000 0.998 0.002
X68.8 Other specified place
0.000 0.998 0.002
X68.7 Farm
0.000 0.998 0.002
X68.6 Industrial and construction area
0.000 0.998 0.002
X68.5 Trade and service area
0.000 0.998 0.002
X68.4 Street and highway
0.000 0.998 0.002
X68.3 Sports and athletics area
0.000 0.998 0.002
X68.2 School, other institution and public administrative area
0.000 0.998 0.002
X68.1 Residential institution
0.000 0.998 0.002
X68.0 Home
0.000 0.998 0.002
Q25.4 Other congenital malformations of aorta
0.002 0.998 0.000
S72.9 Fracture of femur, part unspecified
0.000 0.998 0.002
X78.2 School, other institution and public administrative area
0.000 0.998 0.002
D84 Other immunodeficiencies
0.002 0.998 0.000
X78.9 Unspecified place
0.000 0.998 0.002
X78.8 Other specified place
0.000 0.998 0.002
X78.7 Farm
0.000 0.998 0.002
X78.6 Industrial and construction area
0.000 0.998 0.002
X78.5 Trade and service area
0.000 0.998 0.002
X78.4 Street and highway
0.000 0.998 0.002
X78.3 Sports and athletics area
0.000 0.998 0.002
X78.1 Residential institution
0.000 0.998 0.002
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.002 0.998 0.000
X65.9 Unspecified place
0.000 0.998 0.002
X65.0 Home
0.000 0.998 0.002
X65.7 Farm
0.000 0.998 0.002
X65.6 Industrial and construction area
0.000 0.998 0.002
X65.5 Trade and service area
0.000 0.998 0.002
X65.4 Street and highway
0.000 0.998 0.002
X65.3 Sports and athletics area
0.000 0.998 0.002
X65.2 School, other institution and public administrative area
0.000 0.998 0.002
X65.1 Residential institution
0.000 0.998 0.002
D50 Iron deficiency anaemia
0.002 0.998 0.000
M19.01 Primary arthrosis of other joints (Shoulder region)
0.000 0.998 0.002
Q28.0 Arteriovenous malformation of precerebral vessels
0.002 0.998 0.000
X69.9 Unspecified place
0.000 0.998 0.002
D52.8 Other folate deficiency anaemias
0.002 0.998 0.000
D52.1 Drug-induced folate deficiency anaemia
0.002 0.998 0.000
D52.0 Dietary folate deficiency anaemia
0.002 0.998 0.000
S72.7 Multiple fractures of femur
0.000 0.998 0.002
X83.9 Unspecified place
0.000 0.998 0.002
X84.0 Home
0.000 0.998 0.002
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified
0.002 0.998 0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions
0.002 0.998 0.000
Q20.6 Isomerism of atrial appendages
0.002 0.998 0.000
Q20.5 Discordant atrioventricular connexion
0.002 0.998 0.000
Q20.4 Double inlet ventricle
0.002 0.998 0.000
Q20.3 Discordant ventriculoarterial connexion
0.002 0.998 0.000
Q20.2 Double outlet left ventricle
0.002 0.998 0.000
Q20.1 Double outlet right ventricle
0.002 0.998 0.000
Q20.0 Common arterial trunk
0.002 0.998 0.000
S72.2 Subtrochanteric fracture
0.000 0.998 0.002
X84.8 Other specified place
0.000 0.998 0.002
X84.7 Farm
0.000 0.998 0.002
X84.6 Industrial and construction area
0.000 0.998 0.002
X84.5 Trade and service area
0.000 0.998 0.002
X84.4 Street and highway
0.000 0.998 0.002
X84.3 Sports and athletics area
0.000 0.998 0.002
X84.2 School, other institution and public administrative area
0.000 0.998 0.002
X84.1 Residential institution
0.000 0.998 0.002
Q26.9 Congenital malformation of great vein, unspecified
0.002 0.998 0.000
Q26.8 Other congenital malformations of great veins
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.